|
Volumn 53, Issue 4, 2002, Pages 347-354
|
The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide
a,b a a a a a |
Author keywords
Bioavailability; Morphine; Morphine 6 glucuronide; Pharmacokinetics
|
Indexed keywords
MORPHINE 6 GLUCURONIDE;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BIOLOGICAL MONITORING;
BLOOD PRESSURE;
BREATHING RATE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EFFECT;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG HYDROLYSIS;
DRUG INFUSION;
DYSPNEA;
FEMALE;
HUMAN;
MALE;
MEDICAL RECORD;
NEBULIZATION;
NORMAL HUMAN;
PEAK EXPIRATORY FLOW;
PRIORITY JOURNAL;
PULSE PRESSURE;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
SENSATION;
STANDARDIZATION;
TOXICITY;
ADMINISTRATION, INHALATION;
ADMINISTRATION, ORAL;
ADULT;
AKATHISIA, DRUG-INDUCED;
ANALGESICS, OPIOID;
BIOLOGICAL AVAILABILITY;
FEMALE;
HALF-LIFE;
HUMANS;
INJECTIONS, INTRAVENOUS;
INJECTIONS, SUBCUTANEOUS;
MALE;
MORPHINE DERIVATIVES;
NEBULIZERS AND VAPORIZERS;
|
EID: 0036227490
PISSN: 03065251
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2125.2002.01554.x Document Type: Article |
Times cited : (54)
|
References (36)
|